Breaking News Instant updates and real-time market news.

LGND

Ligand

$97.32

-1.22 (-1.24%)

18:19
10/07/16
10/07
18:19
10/07/16
18:19

Ligand partner Lundbeck announces FDA approval of Carnexiv injection

Ligand Pharmaceuticals partner Lundbeck announced today that the U.S. FDA has approved Carnexiv injection as a short-term replacement therapy for oral carbamazepine formulations in adults with certain seizure types when oral administration is temporarily not feasible. Carnexiv received orphan drug designation for this indication and will be the first available intravenous formulation of the antiepileptic drug carbamazepine. Lundbeck plans to make Carnexiv commercially available in the United States in early 2017. With the approval, Ligand has earned a $1.25M milestone payment. Ligand is also entitled to receive a royalty of 2.75% on net sales of Carnexiv.

LGND Ligand
$97.32

-1.22 (-1.24%)

09/07/16
ROTH
09/07/16
NO CHANGE
Target $149
ROTH
Buy
Ligand has 'major catalyst' ahead, says Roth Capital
Roth Capital analyst Joseph Pantginis says Ligand (LGND) is expecting a "major catalyst" this month namely the Phase IIb sparsentan data in focal segmental glomerulosclerosis patients being developed by partner Retrophin (RTRX). In a separate note to investors, Pantginis also said that the Breakthrough Therapy Designation of SAGE Therapeutics' (SAGE) '547 for postpartum depression may expedite its development and approval for use in the clinic, noting that the company has an agreement of 3% royalty payment to Ligand for potential sales of the drug. The analyst recommends steady accumulation of Ligand's stock as he anticipates that current revenue streams from partnered products and the broad "in development" portfolio are poised to drive significant growth in the near and longer term. He reiterates a Buy rating and $149 price target on Ligand's shares.
09/07/16
ROTH
09/07/16
NO CHANGE
Target $151
ROTH
Buy
Ligand target raised to $151 after sparsentan data at Roth Capital
Roth Capital analyst Joseph Pantginis raised his price target for Ligand Pharmaceuticals (LGND) to $151 from $149 after the company's partner Retrophin (RTRX) announced positive data from the sparsentan Phase II study in focal segmental glomerulosclerosis patients. The analyst believes the data support a potential accelerated path forward and he reminds investors that FSGS has no approved therapies. Pantginis calls the data an important win for Ligand and Retrophin. He keeps a Buy rating on Ligand. The stock is up 7% to $115.21 in early trading.
09/07/16
09/07/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. ConocoPhillips (COP) upgraded to Hold from Underperform at Jefferies with analyst Jason Gammel citing valuation and improving financial metrics. 2. DineEquity (DIN) upgraded to Overweight from Sector Weight at KeyBanc with analyst Chris O'Cull saying the stock has reached a good entry point, while its risk/reward ratio is "compelling." 3. Gaming and Leisure Properties (GLPI) upgraded to Overweight at Morgan Stanley. 4. Aviva (AV) upgraded to Buy from Neutral at UBS with the firm saying the company is positioned to be the risk-adjusted dividend leader in the sector. 5. Ligand (LGND) upgraded to Hold from Sell at Deutsche Bank. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/05/16
HCWC
10/05/16
NO CHANGE
Target $160
HCWC
Buy
Ligand price target raised to $160 from $146 at H.C. Wainwright
H.C. Wainwright analyst Carol Ann Werther raised her price target for Ligand Pharmaceuticals to $160 citing three recent positive events, namely positive Phase II focal segmental glomerulosclerosis data from partner Retrophin, the beginning of a Phase II clinical trial with LGD-6972 for the treatment of type 2 diabetes and the licensing of several therapeutic programs to Seelos. Werther keeps a Buy rating on Ligand.

TODAY'S FREE FLY STORIES

LOGI

Logitech

$37.02

0.46 (1.26%)

17:02
06/28/17
06/28
17:02
06/28/17
17:02
Hot Stocks
Logitech nominates to new directors, proposes 10% dividend increase »

Logitech announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

BLCM

Bellicum Pharmaceuticals

$13.32

0.18 (1.37%)

17:00
06/28/17
06/28
17:00
06/28/17
17:00
Syndicate
Breaking Syndicate news story on Bellicum Pharmaceuticals »

Bellicum files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

XLF

Financial Select Sector

$24.52

0.38 (1.57%)

17:00
06/28/17
06/28
17:00
06/28/17
17:00
Technical Analysis
Technical View: Financial Select Sector rises in extended trading »

The Financial Select…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$65.18

0.95 (1.48%)

16:58
06/28/17
06/28
16:58
06/28/17
16:58
Technical Analysis
Technical View: Citi rises after hours »

In the extended session…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 14

    Jul

  • 20

    Jul

  • 25

    Jul

BAC

Bank of America

$23.88

0.61 (2.62%)

16:54
06/28/17
06/28
16:54
06/28/17
16:54
Hot Stocks
Bank of America to boost quarterly dividend 60%, authorizes $12B share buyback »

Bank of America announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNSL

Consolidated Communications

$21.27

0.53 (2.56%)

, FRP

FairPoint

$15.50

0.5 (3.33%)

16:54
06/28/17
06/28
16:54
06/28/17
16:54
Hot Stocks
Consolidated Communications-FairPoint merger secures regulatory approvals »

Consolidated…

CNSL

Consolidated Communications

$21.27

0.53 (2.56%)

FRP

FairPoint

$15.50

0.5 (3.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$153.24

2.66 (1.77%)

16:54
06/28/17
06/28
16:54
06/28/17
16:54
Periodicals
Facebook creating ad targeting for families, Axios reports »

Facebook is creating new…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

  • 19

    Jul

NTRS

Northern Trust

$96.66

1.24 (1.30%)

16:52
06/28/17
06/28
16:52
06/28/17
16:52
Hot Stocks
Northern Trust to increase dividend to 42c per share, buy back $750M in stock »

Northern Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

SBOT

Stellar Biotechnologies

$1.23

-0.05 (-3.91%)

16:51
06/28/17
06/28
16:51
06/28/17
16:51
Hot Stocks
Breaking Hot Stocks news story on Stellar Biotechnologies »

Frank R. Oakes reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMA

Comerica

$71.94

0.14 (0.19%)

16:51
06/28/17
06/28
16:51
06/28/17
16:51
Hot Stocks
Comerica plans to increase dividend 15%, buy back up to $605M of common stock »

Comerica announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$89.82

1.77 (2.01%)

16:50
06/28/17
06/28
16:50
06/28/17
16:50
Hot Stocks
JPMorgan to up quarterly dividend to 56c/share, authorizes $19.4B share buyback »

JPMorgan Chase & Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jul

  • 12

    Oct

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

BBVA

Banco Bilbao

$8.54

0.16 (1.91%)

16:50
06/28/17
06/28
16:50
06/28/17
16:50
Hot Stocks
BBVA Compass receives no objection to its 2017 capital plan »

BBVA Compass Bancshares,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

ZION

Zions Bancorp

$42.97

0.43 (1.01%)

16:49
06/28/17
06/28
16:49
06/28/17
16:49
Hot Stocks
Zions to boost common dividend to 24c per share by 2Q18 »

The Board of Governors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$123.40

2.28 (1.88%)

16:48
06/28/17
06/28
16:48
06/28/17
16:48
Hot Stocks
PNC says proposed capital plans include 36% dividend hike, $2.7B in buybacks »

The PNC Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jul

MBUU

Malibu Boats

$25.75

0.28 (1.10%)

16:47
06/28/17
06/28
16:47
06/28/17
16:47
Hot Stocks
Malibu Boats to acquire Cobalt Boats for $130M »

Malibu Boats announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CIT

CIT Group

$48.61

0.27 (0.56%)

16:47
06/28/17
06/28
16:47
06/28/17
16:47
Hot Stocks
CIT Group receives no objection to its 2017 capital plan »

CIT Group announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DFS

Discover

$61.88

0.81 (1.33%)

16:47
06/28/17
06/28
16:47
06/28/17
16:47
Hot Stocks
Discover to boost quarterly dividend to 35c per share, authorizes $2.23B buyback »

Discover Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

AMZN

Amazon.com

$990.33

13.55 (1.39%)

, WMT

Wal-Mart

$76.51

0.5 (0.66%)

16:46
06/28/17
06/28
16:46
06/28/17
16:46
Periodicals
Amazon holds first ever 'meet and greet' for sellers, Bloomberg says »

Amazon (AMZN) is holding…

AMZN

Amazon.com

$990.33

13.55 (1.39%)

WMT

Wal-Mart

$76.51

0.5 (0.66%)

EBAY

eBay

$35.31

0.4 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

STI

SunTrust

$56.09

0.88 (1.59%)

16:46
06/28/17
06/28
16:46
06/28/17
16:46
Hot Stocks
SunTrust boosts quarterly dividend 54%, authorizes $1.32B share buyback »

SunTrust Bank announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

KEY

KeyCorp

$18.38

0.18 (0.99%)

16:44
06/28/17
06/28
16:44
06/28/17
16:44
Hot Stocks
KeyCorp to boost quarterly dividend to 10.5c per share, to repurchase $800M »

KeyCorp announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BK

BNY Mellon

$50.60

0.92 (1.85%)

16:43
06/28/17
06/28
16:43
06/28/17
16:43
Hot Stocks
BNY Mellon to raise dividend 24%, repurchase up to $3.1B of common stock »

BNY Mellon announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

CFG

Citizens Financial

$35.34

0.5 (1.44%)

16:42
06/28/17
06/28
16:42
06/28/17
16:42
Hot Stocks
Citizens Financial plans 18c per share quarterly dividends, $850M share buyback »

Citizens Financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

FITB

Fifth Third

$25.49

0.4 (1.59%)

, VNTV

Vantiv

$63.47

1.09 (1.75%)

16:41
06/28/17
06/28
16:41
06/28/17
16:41
Hot Stocks
Fifth Third to raise dividend to 16c, repurchase $1.161B of common stock »

Fifth Third Bancorp…

FITB

Fifth Third

$25.49

0.4 (1.59%)

VNTV

Vantiv

$63.47

1.09 (1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Jul

BBT

BB&T

$44.78

0.96 (2.19%)

16:41
06/28/17
06/28
16:41
06/28/17
16:41
Hot Stocks
BB&T says proposed capital plans include 10% dividend hike, $1.88B in buybacks »

BB&T announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 19

    Oct

MBUU

Malibu Boats

$25.75

0.28 (1.10%)

16:40
06/28/17
06/28
16:40
06/28/17
16:40
Hot Stocks
Breaking Hot Stocks news story on Malibu Boats »

Malibu Boats trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.